There are 2789 resources available
715P - Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcSé prospective program
Presenter: Damien Pouessel
Session: ePoster Display
798P - A phase II study of pembrolizumab (P) in combination with doxorubicin (D) in advanced endometrial cancer (AEC): TOPIC trial/VHIO10001
Presenter: Lorena Fariñas-Madrid
Session: ePoster Display
799P - Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial
Presenter: Wei Wei
Session: ePoster Display
800P - Tailoring adjuvant treatments in high-risk early stage endometrial cancer: Clinical outcomes of sequential chemoradiation in a real-word scenario
Presenter: Marco de Scordilli
Session: ePoster Display
719TiP - SunRISe-1: Phase IIb study of TAR-200 in combination with cetrelimab (CET), TAR-200 alone, or CET alone in participants with high risk non-muscle invasive bladder cancer unresponsive to intravesical bacillus Calmette-Guérin who are ineligible for or elected not to undergo radical cystectomy
Presenter: Michiel van der Heijden
Session: ePoster Display
802P - A machine learning-based framework for efficacy and safety analysis of PD-1PD-L1 inhibitor application in gynaecological cancer on incomplete post-marketing surveillance dataset
Presenter: xiaomei Liu
Session: ePoster Display
803P - An histopathological algorithm to help the search for POLE mutated endometrial cancers
Presenter: Leslie Tessier
Session: ePoster Display
632P - Differential transcriptomic profiling of BCL2-related genes in primary tumor (PT) and metastatic sites (MS) of prostate cancer (PCa)
Presenter: Benedito A Carneiro
Session: ePoster Display
633P - Mutational landscape differences between young-onset and older-onset prostate cancer patients
Presenter: Yong Wang
Session: ePoster Display